Colorectal Cancer Payment Fairness Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
Eliminates Medicare beneficiary coinsurance for certain colorectal cancer screening tests beginning in 2026 by moving the federal payment share to 100 percent.
Who Benefits and How
Medicare beneficiaries receiving covered colorectal cancer screening tests could face no coinsurance for those services beginning in 2026, reducing out-of-pocket barriers to screening.
Who Bears the Burden and How
Federal Medicare spending would absorb the beneficiary share sooner than under current law, and program administrators would need to implement the accelerated phaseout.
Key Provisions
- Removes language that would have limited the coinsurance elimination through January 1, 2030.
- Changes the phase-in schedule so the prior rate applies only through 2025.
- Sets the federal payment percentage for 2026 and each subsequent year at 100 percent for the covered screening tests.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.
At a Glance
What This Bill Does
Eliminates Medicare beneficiary coinsurance for certain colorectal cancer screening tests beginning in 2026 by moving the federal payment share to 100 percent.
Key Policy Areas
Health, Medicare
Primary Purpose
Eliminates Medicare beneficiary coinsurance for certain colorectal cancer screening tests beginning in 2026 by moving the federal payment share to 100 percent.
Policy Domains
Main Provisions
Identified Gains
Contextual inference, no direct clause citation- Medicare beneficiaries receiving covered colorectal cancer screening tests
Contextual inference, no direct clause citation
Identified Costs
Contextual inference, no direct clause citation- Federal Medicare spending and administrators implementing the accelerated coinsurance elimination
Contextual inference, no direct clause citation
Sponsors
Legislative Progress
In CommitteeMr. Booker (for himself and Mr. Heinrich) introduced the following …
Read twice and referred to the Committee on Environment and …
Introduced in Senate
Stakeholder Effects
cui bono?How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.
Medicare beneficiaries receiving covered colorectal cancer screening tests
Federal Medicare spending responsible for the former beneficiary share
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology